Skip to main content

Table 1 Comparison between both groups as regards TEOAEs SNR across different frequencies without contralateral suppression

From: Evaluation of cochlear and auditory brainstem functions in COVID-19 patients; a case control study

 

Study group

Control group

Test value

P-value

No. = 59 ears

No. = 30 ears

TEOAEs SNR

1 KHz

Mean±SD

17.45 ± 6.94

16.74 ± 6.07

0.478

0.634

Range

-9.4 - 32.7

-3.9 - 23

1.4 KHz

Mean±SD

21.82 ± 5.73

21.95 ± 5.09

-0.107

0.915

Range

-0.3 - 32.3

4.9 – 29

2 KHz

Mean±SD

19.74 ± 5.02

20.20 ± 4.34

-0.424

0.672

Range

7.9 – 31

7.8 - 26.9

2.8 KHz

Mean±SD

14.69 ± 5.78

18.62 ± 7.01

-2.817

0.006

Range

3.5 - 26.6

6.3 – 32.9

4 KHz

Mean±SD

16.22 ± 5.04

18.65 ± 5.69

-2.061

0.042

Range

0.4 - 24.7

3.6- 28.3

  1. P<0.05: significant, p<0.01: highly significant, p>0.05: non-significant, TEOAE Transient evoked otoacoustic emissions